Foot manifestations in a patient with COVID-19 and Epstein-Barr virus: A case study.

Szczegóły
Abstrakt

Tytuł:: Foot manifestations in a patient with COVID-19 and Epstein-Barr virus: A case study.
Autorzy:: Nirenberg MS; Friendly Foot Care, PC, Crown Point, IN 46307, USA. Electronic address: .
Herrera MDMR; Clínica María del Mar Ruiz, Calle Trinidad, N.º 14, Alcázar de San Juan (Ciudad Real), 13600, Spain.
Źródło:: Foot (Edinburgh, Scotland) [Foot (Edinb)] 2021 Mar; Vol. 46, pp. 101707. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji:: Case Reports; Journal Article
Język:: English
Imprint Name(s):: Original Publication: Edinburgh ; New York : Churchill Livingstone, c1991-
MeSH Terms:: Toes*
COVID-19/*complications
Epstein-Barr Virus Infections/*complications
Erythema/*drug therapy
Erythema/*virology
Glucocorticoids/*therapeutic use
Hydrocortisone/*therapeutic use
Administration, Topical ; Adolescent ; Female ; Glucocorticoids/administration & dosage ; Humans ; Hydrocortisone/administration & dosage ; Spain
References:: J Am Podiatr Med Assoc. 2023 Mar-Apr;113(2):. (PMID: 32366113)
Br J Dermatol. 2020 Jul;183(1):71-77. (PMID: 32348545)
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. (PMID: 32215952)
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293. (PMID: 32330334)
Int J Infect Dis. 2020 Jul;96:355-358. (PMID: 32437936)
JAAD Case Rep. 2020 Apr 18;6(6):489-492. (PMID: 32363225)
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006. (PMID: 32220276)
J Dtsch Dermatol Ges. 2009 Apr;7(4):309-16. (PMID: 18803578)
J Am Acad Dermatol. 2020 Sep;83(3):e241. (PMID: 32497704)
J Dtsch Dermatol Ges. 2009 May;7(5):414-9. (PMID: 18808380)
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e250-e251. (PMID: 32294264)
Lancet Infect Dis. 2021 Jan;21(1):24-25. (PMID: 32437697)
Actas Dermosifiliogr (Engl Ed). 2020 Jun;111(5):426-429. (PMID: 32402369)
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e346-e347. (PMID: 32330324)
Sci Rep. 2021 May 25;11(1):10902. (PMID: 34035353)
Eur J Clin Invest. 2020 Jun;50(6):e13241. (PMID: 32307717)
Int J Dermatol. 2020 Jun;59(6):739-743. (PMID: 32329897)
Contributed Indexing:: Keywords: COVID Epstein-Barr virus; COVID feet; COVID toes; COVID-19; SARS-CoV-2
Substance Nomenclature:: 0 (Glucocorticoids)
WI4X0X7BPJ (Hydrocortisone)
Entry Date(s):: Date Created: 20201011 Date Completed: 20210422 Latest Revision: 20231111
Update Code:: 20240105
PubMed Central ID:: PMC7313890
DOI:: 10.1016/j.foot.2020.101707
PMID:: 33039244
: Czasopismo naukowe

Full Text Finder

SARS-CoV-2 (COVID-19) is highly-contagious. It can lead to respiratory distress-and in some cases-death. Recent reports and observations have identified an association between COVID-19 and manifestations in the feet. However, there are very few reports that describe the course of these foot manifestations in any detail. The authors present a case study chronicling the progression of foot issues in a COVID-19 positive patient who also was positive for the Epstein-Barr virus.
(Copyright © 2020 Elsevier Ltd. All rights reserved.)

Informacja